Patents Assigned to Roche Diabetes Care, Inc.
-
Patent number: 12042145Abstract: An insertion device includes an insertion component that inserts a medical device into body tissue of a user. The insertion device also includes an insertion component retractor, a cap, a guide sleeve having a ramp, an insertion sleeve and an elastic member. For inserting the medical device, the cap, the insertion component retractor and the insertion sleeve are movable relative to the guide sleeve from a distal position to a proximal position. The ramp twists the insertion component retractor relative to the guide sleeve and the insertion sleeve when the cap is moved from its distal position to its proximal position. The cap is movable from its proximal position to its distal position and the insertion component retractor is thereby moved from its proximal position to its distal position. An associated method of using the insertion device is also disclosed.Type: GrantFiled: March 24, 2023Date of Patent: July 23, 2024Assignee: Roche Diabetes Care, Inc.Inventor: Hans List
-
Patent number: 12042274Abstract: A sensor device for detecting at least one analyte in a body fluid of a user. The sensor device includes an evaluation device for evaluating a data stream of time-dependent concentrations c of the analyte. The evaluation device includes a comparator device for comparing a current value c(t) of the concentration c with a first threshold value L and a second threshold value H, wherein H>L. The evaluation device defines a tolerance time interval. Further, the evaluation device, by using the comparator device, is configured to detect if the concentration c rises and exceeds the first threshold value L during the tolerance time interval and to prepare a warning signal W accordingly. The evaluation device is configured to suppress an output of the warning signal W at least until the tolerance time interval expires, under the precondition that c(t)<H during the tolerance time interval.Type: GrantFiled: October 31, 2018Date of Patent: July 23, 2024Assignee: Roche Diabetes Care, Inc.Inventors: Christian Ringemann, Bernd Steiger
-
Publication number: 20240225500Abstract: The application concerns a stickpack-type packaging comprising an elongate foil tube having two transverse sealing joints, such that a tightly closed fill space is provided in the foil tube for storing a product. It is proposed that a single disposable test strip is arranged in the fill space, wherein the test strip has a chemistry pad for detecting an analyte in a sample, and the chemistry pad is arranged at a distance at least from one of the transverse sealing joints.Type: ApplicationFiled: December 29, 2023Publication date: July 11, 2024Applicant: Roche Diabetes Care, Inc.Inventor: Axel Ahl
-
Patent number: 12024735Abstract: Detection reagents, multi-analyte test elements, test systems, and multi-analyte measuring methods are provided. In particular, multi-analyte test elements have (1) a first working electrode and first counter electrode pair covered with a first analyte-specific reagent that includes an enzyme, a coenzyme and a first mediator and have (2) a second working electrode covered with a second analyte-specific reagent that includes an enzyme, a coenzyme and a second mediator, where the second mediator is different than the first mediator. The single counter electrode can be used as the counter electrode for both the first and second analyte measurements at their respective working electrodes. Moreover, the mediator concentrations, measurement ranges, and applied potential differences are not the same for each analyte-specific measurement.Type: GrantFiled: December 10, 2021Date of Patent: July 2, 2024Assignee: Roche Diabetes Care, Inc.Inventors: Harvey Buck, Terry A. Beaty, Stacy Hunt DuVall
-
Patent number: 12016683Abstract: Disclosed is a portable device for processing continuous monitoring data. The portable device includes a data interface that receives a stream of continuous monitoring data from a body-worn sensor. The data is indicative of an analyte in a bodily fluid. The portable device also includes a storage device that can store the continuous monitoring data. The control processes the continuous monitoring data and is switchable between first and second modes of operation during a sensor session of the body-worn sensor. In the first mode of operation, the control is configured to provide video data indicative of the continuous monitoring data for outputting by a display. In the second mode of operation the control is configured to store the continuous monitoring data in the storage device and to block the continuous monitoring data from being displayed on the display. A related method, system and computer program product are also disclosed.Type: GrantFiled: December 22, 2017Date of Patent: June 25, 2024Assignee: Roche Diabetes Care, Inc.Inventors: Bernd Steiger, Wilfried Schmidt
-
Patent number: 12016686Abstract: A fully implantable sensor for detecting an analyte in a body fluid sample is disclosed. The sensor includes a chamber plate that receives the body fluid sample. The chamber plate has a biocompatible polymer membrane having a molecular weight cutoff of at least 15 kDa. The sensor also includes a quantum cascade laser illumination source that generates an illumination light beam in a spectral range and transmits the light beam to the chamber plate. In response to the illumination light beam at least partially illuminating the chamber plate, the chamber plate generates a reflection light beam that at least partially illuminates the body fluid sample within the chamber plate. The sensor has an optical detector that detects at least one property of the reflection light beam and generates a sensor signal that correlates to the presence of the analyte. The sensor includes a controller to evaluate the sensor signal.Type: GrantFiled: December 28, 2020Date of Patent: June 25, 2024Assignee: Roche Diabetes Care, Inc.Inventor: Katharina Isensee
-
Publication number: 20240201123Abstract: The present invention relates to an analyte sensor comprising a substrate, at least one first electrode, at least one second electrode and at least one protective layer covering the at least one second electrode. The present invention further relates to a process for manufacturing the inventive analyte sensor as well as to an analyte sensor system comprising an analyte sensor according to the present invention and an electronics unit. The analyte sensor according to the present invention may mainly be used for conducting analyte measurements in a body fluid of a user.Type: ApplicationFiled: February 26, 2024Publication date: June 20, 2024Applicant: Roche Diabetes Care, Inc.Inventor: Alexander Steck
-
Patent number: 12011267Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.Type: GrantFiled: July 31, 2023Date of Patent: June 18, 2024Assignee: ROCHE DIABETES CARE, INC.Inventor: Helmut Walter
-
Patent number: 12011268Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and-a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.Type: GrantFiled: July 31, 2023Date of Patent: June 18, 2024Assignee: ROCHE DIABETES CARE, INC.Inventor: Helmut Walter
-
Publication number: 20240194316Abstract: A user device (e.g., a mobile device) may determine a first notification visibility level for the user health-related event based on a context. The user device may receive data associated with the user health-related event. The user device may determine an adherence level for the user health-related event based on the data associated with the user health-related event. The user device may determine a second notification visibility level for the user health-related event based on comparison of the adherence level to a plurality of predefined adherence thresholds. The user device may communicate, using the second notification visibility level, a notification associated with the user health-related event via the user device upon detection of a triggering event. The user device may group, based on the context, one or more user health-related events into a notification group.Type: ApplicationFiled: February 16, 2024Publication date: June 13, 2024Applicant: Roche Diabetes Care, Inc.Inventor: Paul J. Galley
-
Publication number: 20240185992Abstract: A device and method are disclosed for supporting a patient with a disease, comprising a display facility, a user interface, a processor, and a user interface, and with an application module comprising program instructions, which are configured, on executing by the processor to bring about the following: providing medical protocols for diagnostic and/or therapeutic purposes, collecting time information concerning a future event which is a trigger for at least one medical protocol, selecting one of the medical protocols which indicates a group of cohesive protocol events which are spaced apart chronologically over a protocol period in accordance with a protocol regime, monitoring a chronological interval between a current date and the future even, and issuing a user start notice concerning the beginning of the medical protocol at a time which from a chronological point of view lies at least by the protocol period before the future event.Type: ApplicationFiled: January 17, 2024Publication date: June 6, 2024Applicant: Roche Diabetes Care, Inc.Inventors: Matthias Essenpreis, Dirk Voelkel, Stefan Weinert
-
Patent number: 11998328Abstract: A medical device for transcutaneously inserting an insertable element into a body tissue. The medical device includes an insertable element and an insertion cannula for subcutaneously inserting the insertable element. The insertable element includes an in vivo distal end for subcutaneous insertion and an ex vivo proximal end. The insertion cannula has a lumen configured to receive the insertable element that is fully or partially enclosed by a wall of the insertion cannula. The wall comprises at least one shape memory alloy wherein the insertion cannula is stored in a first shape configuration and is configured to be transformable into a second shape configuration for insertion.Type: GrantFiled: December 20, 2018Date of Patent: June 4, 2024Assignee: Roche Diabetes Care, Inc.Inventor: Joachim Jäger
-
Patent number: 11998321Abstract: The disclosure relates to a method and system for controlling glucose levels comprising receiving behavioral sensor measurements and analyte sensor measurements, determining a plurality of analyte profiles from continuous analyte sensor measurements; grouping the plurality of analyte profiles into clusters; assigning a selected behavioral parameter or a selected pattern of behavioral parameters to each analyte profile in a first cluster, and providing a treatment recommendation.Type: GrantFiled: May 24, 2019Date of Patent: June 4, 2024Assignee: Roche Diabetes Care, Inc.Inventor: Christian Ringemann
-
Publication number: 20240148292Abstract: The present invention relates to an analyte sensor comprising a substrate, at least one first electrode, at least one second electrode and at least one protective layer covering the at least one second electrode. The present invention further relates to a process for manufacturing the inventive analyte sensor as well as to an analyte sensor system comprising an analyte sensor according to the present invention and an electronics unit. The analyte sensor according to the present invention may mainly be used for conducting analyte measurements in a body fluid of a user.Type: ApplicationFiled: January 18, 2024Publication date: May 9, 2024Applicant: Roche Diabetes Care, Inc.Inventors: Kirill Sliozberg, Alexander Steck
-
Publication number: 20240138729Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.Type: ApplicationFiled: January 9, 2024Publication date: May 2, 2024Applicant: Roche Diabetes Care, Inc.Inventor: Helmut Walter
-
Patent number: 11969245Abstract: Disclosed is an analyte measuring patch for invasive measuring a concentration of an analyte, in particular glucose. The analyte measuring patch includes a sensor with a working electrode (101), a counter electrode (103) and a reference electrode 102). The patch further includes an electronics unit with a microcontroller (1200) and a current measurement unit. The microcontroller (1200) includes a control output (DAC), a first analogue input (ADC-1) and a second analogue input (ADC-2). The control output (DAC) is operatively coupled with a control electrode, the control electrode being either of the working electrode or (101) or the counter electrode (103). The first analogue input (ADC-2) is operatively coupled with a measurement electrode via the current measurement unit, the measurement electrode being either of the working electrode (101) or the counter electrode (103). The second analogue input (ADC-1) is operatively coupled with the reference electrode (102).Type: GrantFiled: March 9, 2017Date of Patent: April 30, 2024Assignee: ROCHE DIABETES CARE, INC.Inventors: Karl-Heinz Koelker, Frederic Wehowski
-
Publication number: 20240130650Abstract: The application concerns a stickpack-type packaging comprising an elongate foil tube having two transverse sealing joints, such that a tightly closed fill space is provided in the foil tube for storing a product. It is proposed that a single disposable test strip is arranged in the fill space, wherein the test strip has a chemistry pad for detecting an analyte in a sample, and the chemistry pad is arranged at a distance at least from one of the transverse sealing joints.Type: ApplicationFiled: December 29, 2023Publication date: April 25, 2024Applicant: Roche Diabetes Care, Inc.Inventor: Axel Ahl
-
Publication number: 20240122509Abstract: The disclosure relates to an analyte sensor comprising a substrate, at least one working electrode, at least one second electrode and a membrane, wherein the membrane is located on top of the second electrode, and the second electrode has at least one first silver layer and at least one second silver layer which at least partially overlap with one another and have different compositions. The sensor includes at least one exposed area of the first silver layer disposed on the exterior of the sensor to provide for direct contact with body fluid when implanted. The disclosure further relates to a process for manufacturing an analyte sensor.Type: ApplicationFiled: December 19, 2023Publication date: April 18, 2024Applicant: Roche Diabetes Care, Inc.Inventors: Kirill Sliozberg, Alexander Steck
-
Patent number: D1023045Type: GrantFiled: March 30, 2022Date of Patent: April 16, 2024Assignee: Roche Diabetes Care, Inc.Inventors: Matthias Koehler, Nils Babion, Gabriele Schoepfer, Lara Valenti, Clinton Young
-
Patent number: D1028282Type: GrantFiled: April 6, 2023Date of Patent: May 21, 2024Assignee: Roche Diabetes Care, Inc.Inventors: Ernest Graeme Harvey, Michel Cadio